Celecoxib versus ibuprofen

by J Wei 2024 Cited by 30tramadol versus ibuprofen, tramadol versus celecoxib, and tramadol versus etoricoxib, respectively. better elaborate the association

celecoxib (Celebrex) versus ibuprofen versus diclofenac ibuprofen versus ketorolac versus diclofenac for acute, nonradicular low back pain.

versus Ibuprofen or Naproxen) trial,1 which evaluated the celecoxib also was compared with ibuprofen, and ibuprofen with naproxen.

This difference was significant for celecoxib compared with placebo (P = 0.0027), but not for ibuprofen versus placebo or for celecoxib versus ibuprofen. The proportion of patients whose OA condition improved from baseline to week 6 was greater in the celecoxib group (49.0%, 74 of 151) than in the ibuprofen (41.1%, 62 of 151) or placebo

translate into more withdrawals for celecoxib versus ibuprofen or diclofenac (Table 3). celecoxib than ibuprofen, but not diclofenac. The

by OH Ahmed 2024was $11,502/QALY versus ibuprofen and $39,799/QALY versus naproxen. In KSA, the. ICER for celecoxib was $3,630/QALY versus ibuprofen and dominant versus

by OH Ahmed 2024In KSA, the ICER for celecoxib was $3,630/QALY versus ibuprofen and dominant versus naproxen. Probabilistic sensitivity analyses in UAE demonstrated celecoxib

ibuprofen group (1.9%) (hazard ratio for celecoxib vs. naproxen coxib versus ibuprofen and of ibuprofen versus naproxen were also

The CLASS trial evaluated celecoxib versus ibuprofen and diclofenac;63 the VIGOR trial evaluated rofecoxib versus naproxen.81 The third trial compared celecoxib